First human trial launches for experimental cancer therapy
Disease control
Recruiting now
This is an early-stage study to test the safety and find the right dose of a new drug called ABX-001. It will be given to adults with advanced solid tumors that have stopped responding to standard treatments. The study will test the drug by itself and also in combination with an …
Phase: PHASE1 • Sponsor: Abalos Therapeutics GmbH • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC